Skip to main content
Flu Season Alert! Alerta de temporada de influenza:

Don’t let germs win this season – protect yourself and your family!

The flu vaccine is your best defense against flu and related complications – PLUS, it is a covered benefit for Texas Children’s Health Plan members! Learn more!

¡No permitas que los gérmenes ganen esta temporada! ¡Protégete a ti y a tu familia!

La vacuna contra la influenza es tu mejor defensa contra la influenza y sus complicaciones. Además, ¡es un beneficio cubierto para los miembros de Texas Children's Health Plan! Aprende más

HHSC to Remove Oxbryta Products from all Formularies as of Oct. 17, 2024

Date: October 4, 2024
Attention: Providers
Effective date: October 10, 2024

Call to action: On September 25, 2024, Pfizer, the manufacturer voluntarily recalled all Oxbryta® (voxelotor) products from worldwide markets due to safety concerns.

Oxbryta will no longer be a covered benefit and will no longer be on the formulary starting October 17, 2024. 

ProductNDC No.
OXBRYTA 500 MG TABLET72786010101
OXBRYTA 300 MG TABLET FOR SUSP72786011102
OXBRYTA 300 MG TABLET FOR SUSP72786011103
OXBRYTA 300 MG TABLET72786010202
OXBRYTA 300 MG TABLET72786010203

Next step for Providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.